Profit structures of list drug companies remarkably improved.

Published: 2005-08-25 06:59:00

Updated: 2005-08-25 06:59:00

The listed drug companies having a fiscal year ended at March 31, reported the business performance of the 1st quarter of FY2005, showing a substantial improvement of their profits largely due to the aggressive marketing activities for their major and new products at 8.44% of sales up and 9.93% o...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK